STAT3 paradoxically stimulates β-catenin expression but inhibits β-catenin function

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Wnt signaling and STAT3 are oncogenic pathways frequently deregulated in colorectal cancer (CRC).
• Understanding the interplay between these pathways is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the biochemical and functional interactions between STAT3 and Wnt signaling (specifically β-catenin) in CRC.
• To determine the regulatory relationship between STAT3 and β-catenin.

Main Methods:

• Gene knockdown and dominant-negative TCF4 expression in nine CRC cell lines.
• Inhibition of STAT3 and β-catenin individually and in combination.
• Immunostaining of 44 CRC tissues to assess STAT3 and β-catenin expression.
• Analysis of cell proliferation and motility.

Main Results:

• STAT3 knockdown reduced β-catenin mRNA and protein levels, suggesting transcriptional regulation.
• IL6-induced STAT3 activation increased β-catenin mRNA.
• Nuclear STAT3 expression correlated with nuclear β-catenin in CRC tissues (P = 0.022).
• Simultaneous knockdown of STAT3 and β-catenin had a weaker effect on cell proliferation than β-catenin knockdown alone.
• Both STAT3 and β-catenin knockdown individually inhibited cell proliferation and motility.

Conclusions:

• STAT3 positively regulates β-catenin at the transcriptional level in CRC.
• β-catenin does not regulate STAT3.
• The STAT3/β-catenin interaction is complex and may modulate β-catenin's proliferative activity, potentially indicating distinct tumor biology.